1. Home
  2. DWSN vs XGN Comparison

DWSN vs XGN Comparison

Compare DWSN & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DWSN

Dawson Geophysical Company

N/A

Current Price

$3.63

Market Cap

99.2M

Sector

Energy

ML Signal

N/A

Logo Exagen Inc.

XGN

Exagen Inc.

N/A

Current Price

$7.50

Market Cap

110.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DWSN
XGN
Founded
1952
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Medical Specialities
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
99.2M
110.7M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
DWSN
XGN
Price
$3.63
$7.50
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$8.86
AVG Volume (30 Days)
184.5K
295.3K
Earning Date
05-12-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
53.85
N/A
EPS
0.14
N/A
Revenue
$145,773,000.00
N/A
Revenue This Year
N/A
$8.12
Revenue Next Year
N/A
$13.00
P/E Ratio
$26.10
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.50
$2.59
52 Week High
$7.85
$12.23

Technical Indicators

Market Signals
Indicator
DWSN
XGN
Relative Strength Index (RSI) 48.04 63.18
Support Level $3.15 $4.08
Resistance Level $3.71 $7.99
Average True Range (ATR) 0.32 0.44
MACD 0.07 -0.08
Stochastic Oscillator 97.78 64.65

Price Performance

Historical Comparison
DWSN
XGN

About DWSN Dawson Geophysical Company

Dawson Geophysical Co provides seismic data acquisition services mainly to providers of multi-client data libraries and directly to onshore oil and natural gas exploration and development companies in the continental U.S. and Canada. The demand for seismic services is largely influenced by drilling and completion activity, exploration budgets, and prevailing and anticipated crude oil and natural gas prices. Its data acquisition crews serve companies engaged in the exploration and development of oil and gas on land and in land-to-water transition areas. The business operates through two reportable segments, with U.S. operations generating the majority of revenue and Canada operations contributing additionally.

About XGN Exagen Inc.

Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.

Share on Social Networks: